Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
Working Capital/Sales

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 5.314.354.425.7610.63

What is the latest Working Capital/Sales ratio of INDOCO REMEDIES ?

The latest Working Capital/Sales ratio of INDOCO REMEDIES is 5.31 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20245.31
Mar20234.35
Mar20224.42
Mar20215.76
Mar202010.63

How is Working Capital/Sales of INDOCO REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2024 5.31
22.07
Mar2023 4.35
-1.58
Mar2022 4.42
-23.26
Mar2021 5.76
-45.81
Mar2020 10.63 -

Other Financial Ratios of INDOCO REMEDIES


Compare Working Capital/Sales ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,999.7 Cr -3.8% -3.3% -14% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,382.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹159,224.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,943.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,588.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹100,704.0 Cr -2.7% -0.1% 40.9% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-3.8%

-3.3%

-14%

SENSEX

-2.2%

-5.9%

7.2%


You may also like the below Video Courses